| Literature DB >> 36157560 |
Oladayo Biya1, Wiedad Roodly Archer1, Julia Rayner2, Ralph Welwean1, Ayodele Jegede3, Sara Jacenko4, Sarah Pallas4, Taiwo Abimbola4, Kirsten Ward4, Eric Wiesen1.
Abstract
Introduction: In July 2012, the National Stop Transmission of Polio (NSTOP) program was established to support the Government of Nigeria in interrupting transmission of poliovirus and strengthen routine immunization (RI). NSTOP has approximately 300 staff members with the majority based at the Local Government Area (LGA) level in northern Nigeria.Entities:
Keywords: Government of Nigeria; National Stop Transmission of Polio (NSTOP) program; poliovirus; program evaluation; routine immunization
Mesh:
Year: 2021 PMID: 36157560 PMCID: PMC9474955 DOI: 10.11604/pamj.supp.2021.40.1.15816
Source DB: PubMed Journal: Pan Afr Med J
Figure 1Location of all NSTOP-supported LGAs in Nigeria and those LGAs sampled for the internal assessment of NSTOP
sample size for cross sectional survey
| Level | Sample size | Method | Respondents |
|---|---|---|---|
| State | 13 | All 12 states and Federal Capital Territory (FCT) | State Immunization Officers |
| Local Government Area (LGA) | 152 | 38 LGAs sampled from 12 States and FCT 114 Non-*NSTOP LGA officers, 3/LGA 38 NSTOP LGA officers, 1/LGA | WHO LGA Facilitator, UNICEF Consultant, Local Immunization Officer NSTOP LGA officer |
| Health facility (HF) | 228 | 114 HFs sampled from 38 LGAs 2 HF officers/LGA | HF-in-charge and Routine Immunization focal person |
NSTOP - National Stop Transmission of Polio
Figure 2Assessment of performance of NSTOP officers by their peers at the local government level (N=111)
perceived effect of NSTOP activities given by non-NSTOP LGA officers during survey (N=111)
| LGA (%) | State (%) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Theme | Sub-theme | Strongly agree | Agree | Neutral | Disagree | Strongly disagree | Strongly agree | Agree | Neutral | Disagree | Strongly disagree | ||
| Perceived effect of NSTOP activities | NSTOP participation has increased effectiveness of the team | 67.89 | 25.69 | 2.75 | 0 | 3.67 | 69.23 | 15.38 | 0 | 7.69 | 7.69 | ||
| NSTOP effectively coordinates its activities with the team | 73.64 | 22.73 | 0 | 0.91 | 2.73 | 69.23 | 23.08 | 0 | 7.69 | 0 | |||
| NSTOP is effective at the health facility and LGA levels | 69.09 | 22.73 | 1.82 | 2.73 | 3.64 | 61.54 | 30.77 | 0 | 0 | 7.69 | |||
| You are prepared to take over NSTOP responsibilities at this level | 8.11 | 8.11 | 18.92 | 23.42 | 41.44 | 15.38 | 23.08 | 30.77 | 15.38 | 15.38 | |||
| LGA (%) | State (%) | ||||||||||||
| Theme | Sub-theme | Negative effect | No effect | Positive effect | Negative effect | No effect | Positive effect | ||||||
| Likely effect of withdrawing NSTOP officers on specific activities | Supportive supervision for RI | 86.49 | 0.9 | 12.61 | 76.92 | 0 | 23.08 | ||||||
| Support for polio SIAs | 85.59 | 1.8 | 12.61 | 76.92 | 0 | 23.08 | |||||||
| Support for training on RI | 85.59 | 1.8 | 12.61 | 76.92 | 0 | 23.08 | |||||||
| Microplanning for RI | 85.32 | 1.83 | 12.84 | 83.33 | 0 | 16.67 | |||||||
| Data management for RI and IPDs | 83.64 | 3.64 | 12.73 | 75 | 8.33 | 16.67 | |||||||
| Support for training on polio SIAs | 81.82 | 5.45 | 12.73 | 53.85 | 23.08 | 23.08 | |||||||
| Vaccine and cold chain management | 81.08 | 6.31 | 12.61 | Not applicable | Not applicable | Not applicable | |||||||
| AFP and other VPDs surveillance | 80.18 | 7.21 | 12.61 | 75 | 8.33 | 16.67 | |||||||
| Social mobilization | 78.38 | 9.01 | 12.61 | Not applicable | Not applicable | Not applicable | |||||||
| Support for outbreak response | 76.36 | 10.91 | 12.73 | 75 | 8.33 | 16.67 | |||||||
baseline and follow up indicators on routine immunization at local government and health facility levels (N=77 LGAs)
| LGA DATA | HF DATA | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Training | BL | FU | Diff. | P-Value | Obs | BL | FU | Diff. | P-Value | Obs |
| Percentage of government staff trained‡ | 59.1 | 86.4 | 27.30 | <0.01* | 74 | 50.1 | 75.4 | 25.28 | <0.01* | 75 |
| Microplanning | ||||||||||
| Presence of Microplan | 89.3 | 92.4 | 3.03 | 0.77 | 66 | 58.8 | 78.8 | 20.00 | <0.01* | 75 |
| Proportion of LGAs with microplans that contain: | ||||||||||
| ID of hard-to-reach populations | 98.1 | 86.8 | -11.32 | 0.03* | 53 | 60.3 | 74.3 | 14.00 | <0.01* | 69 |
| Outreach plan | 70.6 | 100 | 29.41 | <0.01* | 51 | 75.3 | 79.2 | 3.90 | 0.37 | 69 |
| Percentage of HFs yet to receive RI services in 3 months due to: | ||||||||||
| Vaccine stockout | 33.8 | 19.5 | -14.29 | 0.06 | 77 | 8.27 | 0.9 | -7.36 | <0.01* | 62 |
| Staff shortages | 26 | 9.1 | -16.88 | 0.01* | 77 | 23.4 | 3 | -20.47 | <0.01* | 62 |
| Competing priorities | 31.2 | 13 | -18.18 | 0.01* | 77 | 21.7 | 1.7 | -20.03 | <0.01* | 62 |
| Insufficient funding | 28.6 | 19.5 | -9.09 | 0.26 | 77 | 23.6 | 2.14 | -21.44 | <0.01* | 62 |
| Insufficient transport | 28.6 | 15.6 | -12.99 | 0.09 | 77 | 23 | 2.2 | -20.76 | <0.01* | 62 |
| Insecurity or violence | 16.9 | 24.7 | 7.79 | 0.24 | 77 | 6.8 | 1.2 | -5.58 | 0.05 | 62 |
| Stock-outs | ||||||||||
| tOPV | 13.9 | 5.8 | -8.13 | <0.01* | 76 | |||||
| Measles | 31.5 | 11 | -20.55 | <0.01* | 73 | 24.7 | 11.87 | -12.69 | <0.01* | 75 |
| BCG | 25 | 12.5 | -12.5 | 0.06 | 72 | 38.4 | 21.9 | -16.52 | <0.01* | 76 |
| DPT | 9.7 | 5.6 | -4.17 | 0.51 | 72 | 13.4 | 7.6 | -5.84 | 0.05 | 76 |
| Yellow fever | 34.2 | 15.1 | -19.18 | 0.02* | 73 | 23.9 | 11.9 | -12.03 | <0.01* | 75 |
| Individual vaccination record cards | 37 | 23.3 | -13.7 | 0.06 | 73 | 22.6 | 12 | -10.68 | <0.01* | 75 |
| Cold Chain | ||||||||||
| Working thermometer | 86.5 | 82.4 | -4.05 | 0.65 | 74 | 19.3 | 29.6 | 10.31 | 0.03* | 71 |
| Supervision by state officers | ||||||||||
| Supervisory checklist used | 57.4 | 74.5 | 17.02 | 0.04* | 47 | 26.2 | 34.2 | 8.02 | 0.14 | 73 |
| Training for HF staff | 41.9 | 71 | 29.03 | <0.01* | 62 | 41.8 | 54.6 | 12.73 | <0.01* | 76 |
| Monitoring | ||||||||||
| Report feedback received | 41.2 | 58.9 | 17.67 | <0.01* | 76 | |||||
| RI monitoring chart present | 67 | 86.6 | 19.62 | <0.01* | 73 | |||||
| RI monitoring charts up-to-date for current month | 66.4 | 79 | 12.66 | <0.01* | 71 | |||||
BL (baseline), FU (follow-up), Diff (difference), Obs (observations), ID (identification). Unless specified, all data are proportions of LGAs that had characteristic ‘x’ at BL or FU; Difference is a percentage difference; values are obtained from McNemar’s -χ2 tests for proportions, with McNemar’s Exact Test P values used. If variables are continuous, matched t-tests were used to obtain mean values at BL and FU and p values. Obs (observations) Number of matching pairs used for statistical test; mean percentages shown calculated with this denominator. ‡This is a continuous variable. * implies statistical significance at p < 0.05 level
Figure 3NSTOP program expenditure by funding source and program activities, 2012 - 2015